YouTube Facebook LinkedIn Google+ Twitter Xingrss  


COVER STORY

Keeping Score of Your Sequence
Twelve months after the debut of the first personal genomics services, Kevin Davies expectorates and explores the pros, cons, and controversies of “23 et al.”

 

UP FRONT

Complete Genomics Targets ‘The First $1000 Genome’
Sequencing service is on track for spring 2009.

Riding Out the Storm
Nothing Ventured | How VCs can survive the current economy.

The Business of Stem Cells
Insights | Outlook | Stem cell research and therapies are poised to be big business.

Briefs

 

COMPUTATIONAL BIOLOGY

Grappling with the Next-Gen Data Glut 
Storage and data management drain resources even as sequencing speeds up.

 

COMPUTATIONAL DEVELOPMENT

Breathing New Life into Old Drugs
ChanTest scours the Orange Book for drug hopefuls.

 

IT/WORKFLOW

Triple Play
Tripos’ collaboration with Wyeth enhances research and workflow efficiency.

 

CLINICAL RESEARCH

Clarix Joins Phase Forward
Purchase joins EDC and interactive response technology

Double Layer of Semantics
BRIDG aims to synchronize CDISC and HL7 semantics.

Flexibility in Translational Research Informatics
Tools are becoming increasingly crucial to integrate and analyze translational data. 

 

ECONOMIC DEVELOPMENT

A Celebration of Spanish Science
BIOSPAIN 2008 encouraged global biotechnology.

Dutch Drug Development Heats Up
Government, academia, and industry stoke the life sciences fires.

A Scandinavian Bridge to Somewhere
Denmark and Sweden focus on personalized medicine and innovative science. 

 

IN EVERY ISSUE

Decoding a Mystery
By Kevin Davies
FIRST BASE | Decode Genetics struggles to define the business plan in Iceland.

Microsoft: Eyes on the LS Enterprise
By John Russell
THE RUSSELL TRANSCRIPT | Microsoft positions itself to make a life sciences play.

New Products




For reprints and/or copyright permission, please contact  Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.